Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-β-mediated cancer cell invasiveness

Biochemical Journal

Volumn 426, Issue 3, 2010, Pages 327-335

  Matsuura, Isao ^a   Lai, Chen Yu ^a   Chiang, Keng Nan ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Calcium; Matrix metalloproteinase 9 (MMP 9); Metastasis; S100A4; Smad3; Transforming growth factor (TGF )

Indexed keywords

BREAST CANCER CELLS; CANCER CELLS; CELL INVASION; CELL LINES; CELL TYPES; FUNCTIONAL INTERACTION; INVASIVENESS; MATRIX METALLOPROTEINASE-9; METASTASIS; N-TERMINALS; SMALL INTERFERING RNA; TRANSCRIPTIONAL ACTIVITY; TRANSFORMING GROWTH FACTORS; TUMOURS;

BINDING ENERGY; BIOACTIVITY; CALCIUM; CELL CULTURE; ENZYME INHIBITION; PATHOLOGY; PEPTIDES; RNA;

CELLS;

GELATINASE B; METASTATIN 1; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CALCIUM; PROTEIN S 100; S100A4 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL STRAIN MCF 10; CELL STRAIN MDA MB 231; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; CELL LINE; CELL MOTION; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; IMMUNOPRECIPITATION; METABOLISM; NEOPLASM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TWO HYBRID SYSTEM; WESTERN BLOTTING;

BINDING SITES; BLOTTING, WESTERN; CALCIUM; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION; HUMANS; IMMUNOPRECIPITATION; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASMS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; S100 PROTEINS; SMAD3 PROTEIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 77951884383     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20090990     Document Type: Article

References (46)

1. Siegel, P. M. and Massague, J. (2003) Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat. Rev. Cancer 3, 807-821
2. Attisano, L. and Wrana, J. L. (2000) Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12, 235-243
3. Shi, Y. and Massague, J. (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700
4. Derynck, R., Akhust, R. J. and Balman, A. (2001) TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129
5. Massague, J., Blain, S. W. and Lo, R. S. (2000) TGF-β signaling in growth control, cancer and heritable disorders. Cell 103, 295-309
6. Massague, J. (2008) TGF-β in cancer. Cell 134, 215-229
7. Levy, L. and Hill, C. S. (2006) Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17, 41-58
8. Pardali, K. and Moustakas, A. (2006) Actions of TGF-β as tumor suppressor and prometastatic factor in human cancer. Biochem. Biophys. Acta 1775, 21-62
9. Deryugina, E. I. and Quigley, J. P. (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25, 9-34
10. Yoon, S.-O., Park, S.-J., Yun, C.-H. and Chung, A.-S. (2003) Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J. Biochem. Mol. Biol. 36, 128-137
11. Seton-Rogers, S. E., Lu, Y., Hines, L. M., Koundinya, M., LaBaer, J., Muthuswamy, S. K. and Brugge, J. S. (2004) Cooperation of the ErbB2 receptor and transforming growth factor-β in induction of migration and invasion in mammary epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 101, 1257-1262
12. Uttamsingh, S., Bao, X., Nguyen, K. T., Bhanot, M., Gong, J., Chan, J. L., Liu, F., Chu, T. T. and Wang, L.-H. (2007) Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27, 2626-2634
13. Tian, Y.-C., Chen, Y.-C., Chang, C.-T., Hung, C.-C., Wu, M.-S., Phillips, A. and Yang, C.-W. (2007) Epidermal growth factor and transforming growth factor-β1 enhance HK-2 cell migration though a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Exp. Cell Res. 313, 2367-2377
14. Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L. and Arteaga, C. L. (2003) Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor-β1. Mol. Cell. Biol. 23, 8691-8703
15. Chou, Y.-T., Wang, H., Chen, Y., Danielpour, D. and Yang, Y-C. (2006) Cited2 modulates TGF-β-mediated upregulation of MMP9. Oncogene 25, 5547-5560
16. Marenholz, I., Heizman, C. W. and Fritz, G. (2004) S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem. Biophys. Res. Commun. 19, 739-744
17. Rudland, P. S., Platt-Higgins, A. M., Renshaw, C. A., West, C. R., Winstanley, J. H. R., Robertson, L. and Barracolough, R. (2000) Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res. 60, 1595-1603 (Pubitemid 30183430)
18. Gongoll, S., Peters, G., Mengel, M., Piso, P., Klempnauer, J., Kreipe, H. and von Wasielewski, R. (2002) Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123, 1478-1484 (Pubitemid 35231647)
19. Davies, B. R., O'Donnell, M., Durkan, G. C., Rudland, P. S., Barraclough, R., Neal, D. E. and Mellon, J. K. (2002) Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer. J. Pathol. 196, 292-299 (Pubitemid 34189418)
20. Ninomiya, I., Ohta, T., Fushida, S., Endo, Y., Hashimoto, T., Yagi, M., Fujimura, T., Nishimura, G., Tani, T., Shimizu, K. et al. (2001) Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int. J. Oncol. 18, 715-720
21. Platt-Higgins, A. M., Renshaw, C. A., West, C. R., Winstanley, J. H., De Silva Rudland, S., Barracolough, R. and Rudland, P. S. (2000) Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. Int. J. Cancer 89, 198-208
22. Lee, W. Y., Su, W. C., Lin, P. W., Guo, H. R., Chang, T. W. and Chen, H. H. (2004) Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology 66, 429-438
23. Ambartsumian, N. S., Grigorian, M. S., Larsen, I. F., Karlstorm, O., Sidenius, N., Rygaard, J., Georgiev, G. and Lukanidin, E. (1996) Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene 13, 1621-1630
24. Davies, M. P., Rudland, P. S., Robertson, L., Parry, E. W., Jolicoeur, P. and Barraclough, R. (1996) Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumors. Oncogene 13, 1631-1637
25. Grigorian, M., Andersen, S., Tulchinsky, E., Kriajevska, M., Carlberg, C., Kruse, C., Cohn, M., Ambartsumian, N., Christensen, A., Selivanova, G. and Lukanidin, E. (2001) Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein. J. Biol. Chem. 276, 22699-22708
26. Garrett, S. C., Varney, K. M., Weber, D. J. and Bresnick, A. R. (2006) S100A4, a mediator of metastasis. J. Biol. Chem. 281, 677-680
27. Li, Z. H., Spektor, A., Varlamova, O. and Bresnick, A. R. (2003) Mts1 regulates the assembly of nonmuscle myosin-IIA. Biochemistry 42, 14258-14266 (Pubitemid 37499423)
28. Li, Z. and Bresnick, A. R. (2006) The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res. 66, 5173-5180 (Pubitemid 43844940)
29. Matsuura, I., Denissova, N. G., Wang, G., He, D., Long, J. and Liu, F. (2004) Cyclin-dependent kinases regulates antiproliferative function of Smads. Nature 430, 226-231 (Pubitemid 38902433)
30. Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D., Eliason, J., Mohamed, A. N., Wolman, S. R., Heppner, G. H. and Miller, F. R. (2001) Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 65, 101-110
31. Tang, B., Vu, M., Booker, T., Santner, S. J., Miller, F. R., Anver, M. R. and Wakefield, L. M. (2003) TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest. 112, 1116-1124
32. Swift, S., Lorens, J., Achacoso, P. and Nolan, G. P. (1999) Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. In Current Protocols in Immunology (Coligan. J. E., Bierer, B. E., Margulies, D. H., Shevach, E. M., Strober, W. and Coics, R. eds), Unit 10.28, Supplement 31, John Wiley & Sons, New York
33. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L. and Arteaga, C. L. (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810
34. Tian, F., Byfield, S. D., Parks, W. T., Yoo, S., Felici, A., Tang, B., Piek, E., Wakefield, L. M. and Roberts, A. B. (2003) Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res. 63, 8284-8292
35. Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C. R., Manova-Todorova, K., Blasberg, R., Gerald, W. L. and Massague, J. (2005) Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. U.S.A. 102, 13909-13914
36. Deckers, M., van Dinther, M., Buijs, J., Que, I., Lowik, C., van der Pluijm, G. and ten Dijke, P. (2006) The tumor suppressor Smad4 is required for transforming growth factor-β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 66, 2202-2209
37. Zimmerman, C. M., Kariapper, M. S. and Mathews, L. S. (1998) Smad proteins physically interact with calmodulin. J. Biol. Chem. 273, 677-680
38. Scherer, A. and Graff, J. M. (2000) Calmodulin differentially modulates Smad1 and Smad2 signaling. J. Biol. Chem. 275, 41430-41438
39. Prosser, B. L., Wright, N. T., Hernãndez-Ochoa, E. O., Varney, K. M., Liu, Y., Olojo, R. O., Zimmer, D. B., Weber, D. J. and Schneider, M. F. (2008) S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling. J. Biol. Chem. 283, 5046-5057
40. Wright, N. T., Prosser, B. L., Varney, K. M., Zimmer, D. B., Schneider, M. F. and Weber, D. J. (2008) S100A1 and calmodulin compete for the same binding site on ryanodine receptor. J. Biol. Chem. 283, 26676-26683
41. Chen, H., Fernig, D. G., Rudland, P. S., Sparks, A., Wilkinson, M. C. and Barraclough, R. (2001) Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem. Biophys. Res. Commun. 286, 1212-1217
42. Zhang, Y., Feng, X.-H. and Derynck, R. (1998) Smad3 and Smad4 corporate with c-Jun/c-Fos to mediate TGF- β-induced transcription. Nature 394, 909-913
43. Adorno, M., Cordenonsi, M., Dupont, S., Wong, C., Hann, B., Solari, A., Bobisse, S., Rondina, M. B., Guzzardo, V., Parenti, A. R. et al. (2009) A mutant-p53/Smad complex opposes p63 to empower TGF-β-induced metastasis. Cell 137, 87-98
44. Wang, G., Matsuura, I., He, D. and Liu, F. (2009) TGF-β-inducible phosphorylation of Smad3. J. Biol. Chem. 284, 9663-9673
45. Funaba, M., Zimmerman, C. M. and Mathews, L. S. (2002) Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J. Biol. Chem. 277, 41361-41368
46. Lee, W. J., Monteith, G. R. and Roberts-Thomson, S. J. (2006) Calcium transport and signaling in the mammary gland: targets for breast cancer. Biochem. Biophys. Acta 1765, 235-255